Lipid nanoparticle-mediated drug delivery to the brain.

Khare, Purva; Edgecomb, Sara X; Hamadani, Christine M; Tanner, Eden E L; S Manickam, Devika

Khare, Purva; Edgecomb, Sara X; Hamadani, Christine M; Tanner, Eden E L; S Manickam, Devika.

Afiliación

Khare P; Graduate School of Pharmaceutical Sciences, Duquesne University, Pittsburgh, PA, United States.
Edgecomb SX; Department of Chemistry and Biochemistry, The University of Mississippi, MS, United States.
Hamadani CM; Department of Chemistry and Biochemistry, The University of Mississippi, MS, United States.
Tanner EEL; Department of Chemistry and Biochemistry, The University of Mississippi, MS, United States. Electronic address: eetanner@olemiss.edu.
S Manickam D; Graduate School of Pharmaceutical Sciences, Duquesne University, Pittsburgh, PA, United States. Electronic address: soundaramanickd@duq.edu.

Adv Drug Deliv Rev ; 197: 114861, 2023 06.

Article en En | MEDLINE | ID: mdl-37150326

Asunto(s)

COVID-19; Nanopartículas; Humanos; Lípidos; Liposomas; ARN Interferente Pequeño/genética; Encéfalo

Palabras clave

Blood-brain barrier; Ionic liquids; Ionizable cationic lipid; Lipid nanoparticles; Red blood cell hitchhiking

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Nanopartículas / COVID-19 Límite: Humans Idioma: En Revista: Adv Drug Deliv Rev Asunto de la revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Países Bajos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google